Patents by Inventor Lee H. Lorenzen

Lee H. Lorenzen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240165191
    Abstract: Methods for prophylactic and anti-transmissivity uses of an anti-microbial composition are disclosed. The methods comprise the step of administering to a human an amount of a composition having a first ingredient being xylitol; a second ingredient comprised of a glycyrrhizin-protargin-quercetin complex, in addition to formula stabilizing ingredients of glycerol monolaurate, grapefruit seed extract; vitamin C (ascorbic acid), aloe emodin, curcumin, 1,8-cineole, zinc, quinine, flavoring, and an acceptable preservative for use in an oral application. When administered the composition is effective in reducing the incidence of contracting an illness or to prophylactically help prevent transmission of an illness into the or cavity and respiratory tract.
    Type: Application
    Filed: January 31, 2024
    Publication date: May 23, 2024
    Inventor: Lee H. Lorenzen
  • Patent number: 11795083
    Abstract: A method for the creation of structured water in a laboratory or commercial setting may be bottled and distributed for human consumption. The method creates structured water that maintains its specific matrix structure for longer than structured water that is formed naturally (signal-locked water). The method creates signal-locked water by rendering the water prepared with a magnetic field, adding additives, exposing it to electromagnetic radiation, and adding a concentrate. The signal-locked water may be bottled and distributed for purchase and consumption.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: October 24, 2023
    Assignee: Vita Technologies, Inc.
    Inventors: Oliver S. Laurence, Frederick M. Graham, Jr., Lee H. Lorenzen
  • Publication number: 20220080020
    Abstract: Methods for prophylactic and anti-transmissivity uses of an anti-microbial composition are disclosed. The methods comprise the step of administering to a human an amount of a composition having a first ingredient being xylitol; a second ingredient comprised of a glycyrrhizin-protargin-quercetin complex, in addition to formula stabilizing ingredients of glycerol monolaurate, grapefruit seed extract; vitamin C (ascorbic acid), aloe emodin, curcumin, 1,8-cineole, zinc, quinine, flavoring, and an acceptable preservative for use in an oral application. When administered the composition is effective in reducing the incidence of contracting an illness or to prophylactically help prevent transmission of an illness into the or cavity and respiratory tract.
    Type: Application
    Filed: August 23, 2021
    Publication date: March 17, 2022
    Inventors: Luc Montagnier, Lee H. Lorenzen
  • Publication number: 20110318333
    Abstract: There is provided a non-toxic composition and method of using such for treating a degenerative or an immune-related disease. The non-toxic composition comprises a sprouted grain composition comprising digestive enzymes, a clustered water composition, and a substantially undenatured whey protein composition.
    Type: Application
    Filed: September 8, 2011
    Publication date: December 29, 2011
    Inventors: Robert GAUTHIER, Lee H. LORENZEN
  • Publication number: 20080193433
    Abstract: There is provided a non-toxic composition and method of using such for treating a degenerative or an immune-related disease. The non-toxic composition comprises a sprouted grain composition comprising digestive enzymes, a clustered water composition, and a substantially undenatured whey protein composition.
    Type: Application
    Filed: November 28, 2007
    Publication date: August 14, 2008
    Inventors: Robert Gauthier, Lee H. Lorenzen
  • Patent number: 6103218
    Abstract: A composition and delivery system are disclosed that will allow feverfew to be administered to a person in form in which an active ingredient of feverfew, particularly parthenolide can be readily and quickly assimilated by the person's body, particularly the central nervous system, and the therapeutic effects of the feverfew be rapidly imparted to the person. Feverfew is administered in the form of aqueous nasal spray composition, to provide therapeutic moisturization of nasal mucous membranes, relief of migraine headaches and antispasmodic effect, such as to relieve menstrual cramping or aid digestion. The effect is enhanced when the composition also contains nanoclustered resonant water. Vitamins, vitamin derivatives, surfactants, wetting agents, preservatives and emulsifiers may also be present.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: August 15, 2000
    Inventors: Donald Brucker, Lee H. Lorenzen
  • Patent number: 6033678
    Abstract: Microclustered water is produced from a starting water. First, the starting water is boiled to produce steam. Next, the steam is passed across a magnetic field, and the steam is condensed at a temperature greater than 0.degree. C. in the presence of light in the far infra-red to ultraviolet spectrum range to produce condensed steam. At least one metasilicate salt stabilizer and a dietary supplement template are added to the condensed steam. The concentration of dietary supplement template is 1% or less. The condensed steam is exposed to a pressure greater than 1 atmosphere; and then depressurized to produce the microclustered water. The microclustered water produces an .sup.17 O NMR resonance signal less than 115 Hz, has a conductivity of at least 3.7 .mu.s/cm, and has a surface tension of less than 61 dynes/cm.
    Type: Grant
    Filed: December 4, 1997
    Date of Patent: March 7, 2000
    Inventor: Lee H. Lorenzen
  • Patent number: 5711950
    Abstract: A method for preparing microclustered water comprising boiling water to produce steam includes passing the steam across a magnetic field, exposing the steam to light having a wavelength of between 610 nm and 1 mm, condensing the steam at a temperature greater than 0.degree. C., adding at least one stabilizer comprising a metasilicate salt to the condensed steam, adding yeast cells or an antiviral pharmaceutical agent at a concentration of 1% or less to the condensed steam, exposing the condensed steam to a pressure greater than one atmosphere, and depressurizing the condensed steam. The method is useful in the preparation of medicaments, catalysts, agricultural products and other products.
    Type: Grant
    Filed: March 9, 1994
    Date of Patent: January 27, 1998
    Inventor: Lee H. Lorenzen